Acadia Pharmaceuticals isn’t taking its recent rejection from the European Medicines Agency lying down, vowing to seek a ...

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) will request a re-examination of a negative opinion from the European Medicines ...

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...

Taysha Gene Therapies Inc. is set to report fourth-quarter results on Wednesday, as investors weigh the clinical-stage biotech’s deepening losses against progress in its lead gene therapy program for ...

Neuren Pharmaceuticals shares are looking cheap with a solid income stream from its Daybue drug, Macquarie says.

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the ...

Gene therapy offers significant opportunities globally due to its potential in treating genetic disorders. Current strategies involve modified viral vectors for gene delivery, with applications in ...

Broad losses on the ASX; Origin strikes Eraring deal; Northern Minerals rebuffs Chinese move; coal jumps the most in three years; Life360 hit on near term weaknesses. Follow live.

A Portadown man stranded in Tel Aviv says he remains relaxed despite rockets constantly exploding near him - because Israelis remain "as cool as cucumbers" during the ongoing war.

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Jonathan M. Poole to its Board of Directors, ...

US markets recovered off intraday lows on confirmation the US Administration is taking both measures (insurance & defense) to ...

Barrenjoey merger; Northern Minerals rebuffs Chinese move; coal jumps the most in three years; Stockland’s data centre partnership. Follow live.